Hemophilia A Without Inhibitors: Personalizing Therapy With Factor VIII Prophylaxis

Downloadable slides with expert analysis on the use of EHL Factor VIII therapy for patients with hemophilia A.

Guy A. Young, MD Released: October 29, 2020

Downloadable slides with expert analysis on the importance of PK monitoring with EHL Factor VIII therapy for patients with hemophilia A.

Michael Callaghan, MD Released: October 29, 2020

Downloadable slides with expert analysis on the management of cardiovascular and other comorbidities in older patients with hemophilia A.

Miguel A. Escobar, MD Released: October 29, 2020

Download this summary slideset with essential expert insights on the clinical management of patients with hemophilia A.

Michael Callaghan, MD Miguel A. Escobar, MD Guy A. Young, MD Released: November 5, 2020

Our current goals for managing hemophilia have evolved beyond simply preventing bleeding and joint damage—now, we aim to give our patients as full a life as would be possible without hemophilia. Read my take on leveraging extended half-life products and tools for estimating PK profiles to individualize hemophilia prophylaxis.

Michael Callaghan, MD Released: November 20, 2020

Review multidisciplinary perspectives on leveraging clotting factor concentrates for prophylaxis of hemophilia A with this Webcast from a hematology symposium.

Michael Callaghan, MD Miguel A. Escobar, MD Guy A. Young, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit™ Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Released: December 8, 2020 Expired: December 7, 2021